BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18925855)

  • 1. Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead.
    Malagari K
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1643-50. PubMed ID: 18925855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
    Song MJ; Chun HJ; Song DS; Kim HY; Yoo SH; Park CH; Bae SH; Choi JY; Chang UI; Yang JM; Lee HG; Yoon SK
    J Hepatol; 2012 Dec; 57(6):1244-50. PubMed ID: 22824821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
    Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D
    Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-loaded microspheres for the treatment of liver cancer: review of current results.
    Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T
    Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants.
    Namur J; Citron SJ; Sellers MT; Dupuis MH; Wassef M; Manfait M; Laurent A
    J Hepatol; 2011 Dec; 55(6):1332-8. PubMed ID: 21703190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embolization of hepatocellular carcinoma with drug-eluting beads: new insight into the biologic effects of tumor ablation.
    Shouval D
    J Hepatol; 2011 Dec; 55(6):1169-70. PubMed ID: 21806947
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].
    Sousa PF; Preto AS; Leão D; Madureira AM; Paquete J; Costa-Maia J; Vilares-Morgado P
    Acta Med Port; 2011; 24(1):29-36. PubMed ID: 21672439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles.
    Padia SA; Shivaram G; Bastawrous S; Bhargava P; Vo NJ; Vaidya S; Valji K; Harris WP; Hippe DS; Kogut MJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):301-6. PubMed ID: 23380737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
    Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J
    J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.
    Malagari K; Chatzimichael K; Alexopoulou E; Kelekis A; Hall B; Dourakis S; Delis S; Gouliamos A; Kelekis D
    Cardiovasc Intervent Radiol; 2008; 31(2):269-80. PubMed ID: 17999110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.
    Nam HC; Jang B; Song MJ
    World J Gastroenterol; 2016 Oct; 22(40):8853-8861. PubMed ID: 27833376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.
    Malagari K; Pomoni M; Spyridopoulos TN; Moschouris H; Kelekis A; Dourakis S; Alexopoulou E; Koskinas J; Angelopoulos M; Kornezos J; Pomoni A; Tandeles S; Marinis A; Rizos S; Kelekis D
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):774-85. PubMed ID: 21184228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.
    Lewis AL; Gonzalez MV; Lloyd AW; Hall B; Tang Y; Willis SL; Leppard SW; Wolfenden LC; Palmer RR; Stratford PW
    J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):335-42. PubMed ID: 16517780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization.
    Prajapati HJ; Rafi S; El-Rayes BF; Kauh JS; Kooby DA; Kim HS
    J Vasc Interv Radiol; 2012 Oct; 23(10):1286-93.e1. PubMed ID: 22999748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemoembolization of hepatocellular carcinoma with drug eluting beads].
    Kivelä K; Seppänen J; Keski-Nisula L
    Duodecim; 2009; 125(21):2387-93. PubMed ID: 19999664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model.
    Namur J; Wassef M; Millot JM; Lewis AL; Manfait M; Laurent A
    J Vasc Interv Radiol; 2010 Feb; 21(2):259-67. PubMed ID: 20123210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization using doxorubicin beads for unresectable hepatocellular carcinoma.
    Poston GJ
    Onkologie; 2010; 33(1-2):5-6. PubMed ID: 20164653
    [No Abstract]   [Full Text] [Related]  

  • 18. Post embolization syndrome in doxorubicin eluting chemoembolization with DC bead.
    Pomoni M; Malagari K; Moschouris H; Spyridopoulos TN; Dourakis S; Kornezos J; Kelekis A; Thanos L; Chatziioanou A; Hatjimarkou I; Marinis A; Koskinas J; Kelekis D
    Hepatogastroenterology; 2012 May; 59(115):820-5. PubMed ID: 22024228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations.
    Lencioni R; de Baere T; Burrel M; Caridi JG; Lammer J; Malagari K; Martin RC; O'Grady E; Real MI; Vogl TJ; Watkinson A; Geschwind JF
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):980-5. PubMed ID: 22009576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Composition-property relationships for radiopaque composite materials: pre-loaded drug-eluting beads for transarterial chemoembolization.
    Kilcup N; Tonkopi E; Abraham RJ; Boyd D; Kehoe S
    J Biomater Appl; 2015 Jul; 30(1):93-103. PubMed ID: 25690386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.